ABVC BioPharma, Inc. Common Stock (ABVC) Stock Price

ABVCStock

$0.83−73.05%52W

Market Cap$22.12M

P/E—

PEG Ratio—

Div yield—

Beta0.54

ABVC Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-52.64%

Price vs S&P 500 (4W)-21.73%

VGM Score37.01

Book Value / Share (Quarterly)$0.42

P/TBV (Annual)4.71x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)12.28%

Cash Flow / Share (Quarterly)$-0.13

Price vs S&P 500 (YTD)-73.85%

Gross Margin (TTM)0.25%

Net Profit Margin (TTM)-227.24%

EPS (TTM)$-0.42

10-Day Avg Trading Volume0.10M

EPS Excl Extra (TTM)$-0.42

Revenue Growth (5Y)-6.15%

EPS (Annual)$-0.39

ROI (Annual)-62.44%

Gross Margin (Annual)99.85%

Net Profit Margin (5Y Avg)-2674.08%

Cash / Share (Quarterly)$0.01

Revenue Growth QoQ (YoY)104.47%

ROA (Last FY)-37.55%

Revenue Growth TTM (YoY)56.56%

EBITD / Share (TTM)$-0.39

ROE (5Y Avg)-329.42%

Operating Margin (TTM)-256.03%

Cash Flow / Share (Annual)$-0.12

P/B Ratio2.34x

P/B Ratio (Quarterly)2.29x

Net Income / Employee (Annual)$-416,200

EV / Revenue (TTM)32.55x

Net Interest Coverage (TTM)-5.32x

ROA (TTM)-48.17%

EPS Incl Extra (Annual)$-0.39

Current Ratio (Annual)0.41x

Quick Ratio (Quarterly)0.07x

3-Month Avg Trading Volume0.13M

52-Week Price Return-73.05%

Revenue / Employee (TTM)$41,900

Tangible BV / Share (Quarterly)$0.34

P/S Ratio (Annual)49.50x

Asset Turnover (Annual)0.07x

52-Week High$3.40

Operating Margin (5Y Avg)-2421.44%

EPS Excl Extra (Annual)$-0.39

26-Week Price Return-40.71%

Quick Ratio (Annual)0.35x

13-Week Price Return-41.13%

Total Debt / Equity (Annual)0.14x

Current Ratio (Quarterly)0.12x

Enterprise Value$25.97M

Revenue / Share Growth (5Y)-35.78%

Asset Turnover (TTM)0.06x

Book Value / Share Growth (5Y)-20.65%

Revenue / Employee (Annual)$0

Inventory Turnover (Annual)19.33x

Pretax Margin (Annual)-1053.71%

Cash / Share (Annual)$0.03

3-Month Return Std Dev103.28%

Gross Margin (5Y Avg)52.97%

Net Income / Employee (TTM)$-495,900

ROE (Last FY)-71.17%

Net Interest Coverage (Annual)-7.35x

EPS Basic Excl Extra (Annual)$-0.39

P/FCF (TTM)148.39x

Receivables Turnover (TTM)85.00x

Total Debt / Equity (Quarterly)0.08x

EPS Incl Extra (TTM)$-0.42

Receivables Turnover (Annual)85.00x

ROI (TTM)-82.74%

P/S Ratio (TTM)31.62x

Pretax Margin (5Y Avg)-2656.65%

Revenue / Share (Annual)$0.00

Tangible BV / Share (Annual)$0.94

Forward P/E0.63x

Price vs S&P 500 (52W)-91.61%

Year-to-Date Return-61.03%

5-Day Price Return-1.19%

EPS Normalized (Annual)$-0.39

ROA (5Y Avg)-92.58%

Net Profit Margin (Annual)-962.12%

Month-to-Date Return-17.82%

Cash Flow / Share (TTM)$-3.45

EBITD / Share (Annual)$-0.35

Operating Margin (Annual)-873.18%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-181.95%

LT Debt / Equity (Quarterly)0.18x

EPS Basic Excl Extra (TTM)$-0.42

P/TBV (Quarterly)247.13x

P/B Ratio (Annual)4.66x

Inventory Turnover (TTM)19.33x

Pretax Margin (TTM)-244.89%

Book Value / Share (Annual)$0.44

Price vs S&P 500 (13W)-43.09%

Beta0.54x

P/FCF (Annual)840.89x

Revenue / Share (TTM)$0.03

ROE (TTM)-92.02%

52-Week Low$0.71

vGradeD

gGradeB

mGradeD

vgmGradeD

ABVC Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q1 2023	May 15, 2023	-$0.50	-$0.60	-20.00%(-$0.10)
Q4 2022	Mar 31, 2023	-$1.50	-$1.50	+0.00%(+$0.00)
Q3 2022	Nov 14, 2022	-$2.00	-$1.10	+45.00%(+$0.90)
Q2 2022	Aug 15, 2022	-$1.25	-$0.60	+52.00%(+$0.65)

ABVC Analyst Recommendations

Jul 2023

Aug 2023

Sep 2023

Oct 2023

2.17

Industry Peers — Pharmaceuticals(570)

Symbol	Value Score	Growth Score	Momentum Score	Price
ABVCABVC BioPharma, Inc. Common Stock	D	B	D	$0.83
LLYEli Lilly & Co.	D	B	C	$1174.61
JNJJohnson & Johnson	D	C	B	$268.04
ABBVABBVIE INC.	D	C	B	$255.48
MRKMerck & Co., Inc.	D	C	B	$148.35
NVSNovartis AG	C	C	C	$153.81
AZNAstraZeneca PLC	C	B	C	$162.70
NVONovo-Nordisk A/S	B	C	C	$45.61
ABTAbbott Laboratories	C	C	C	$112.47
PFEPfizer Inc.	C	D	B	$27.96
VRTXVertex Pharmaceuticals Inc	D	C	B	$541.69
BMYBristol-Myers Squibb Co.	B	B	B	$66.58
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$44.82
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$50.82
REGNRegeneron Pharmaceuticals Inc	C	C	B	$794.19
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	B	$18.03
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$36.44
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	B	$366.73
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$60.85
ZTSZOETIS INC.	C	C	D	$77.34
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$237.10
INSMInsmed, Inc.	F	A	C	$118.54
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$34.71
UTHRUnited Therapeutics Corp	C	C	B	$515.46
GMABGenmab A/S ADS	C	C	B	$33.23
VTRSViatris Inc. Common Stock	B	C	B	$16.34
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$247.91
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$244.54
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$76.60
BMRNBioMarin Pharmaceuticals Inc	C	C	B	$64.67
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	B	$533.76
CORTCorcept Therapeutics Inc.	F	C	B	$113.88
ELANElanco Animal Health Incorporated Common Stock	C	B	C	$24.11
ARWRArrowhead Research Corporation	D	A	B	$84.91
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.73
AXSMAxsome Therapeutics, Inc	D	B	C	$199.02
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.18
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$61.05
CYTKCytokinetics Inc.	F	D	C	$72.09
ABVXAbivax SA American Depositary Shares	—	—	C	$113.35
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$344.75
PTGXProtagonist Therapeutics, Inc	F	B	B	$144.33
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.84
TGTXTG Therapeutics, Inc.	D	B	B	$53.93
SYRESpyre Therapeutics, Inc. Common Stock	—	—	B	$90.36
ALKSAlkermes Inc. plc	D	C	B	$47.41
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$107.17
ERASErasca, Inc. Common Stock	—	—	A	$18.03
TVTXTravere Therapeutics, Inc. Common Stock	F	B	A	$65.67
BLTEBelite Bio, Inc American Depositary Shares	—	—	C	$151.72

About ABVC BioPharma, Inc. Common Stock

ABVC BioPharma is a clinical-stage biopharmaceutical company developing a pipeline of six drug candidates and a medical device based on botanically-derived therapeutics. The company focuses on proof-of-concept and Phase II clinical trials, leveraging proprietary technology to deliver high efficacy with low toxicity profiles.